Current calls, week 20, 2020
Tips from Grants Office about current calls
Swedish and Nordic calls
Doktorandstipendium - Svensk Sjuksköterskeförening
Syftar till att stimulera omvårdnadsforskning av hög relevans och vetenskaplig kvalitet som en bas för ökad evidensbasering av den kliniska omvårdnaden till gagn för patienter och närstående. Stipendiet är värt SEK 110,000.
Closing date: 4 September 2020
Forskning om förorenade sediment - Naturvårdsverket
Stöder projekt om risker med, och spridning av, förorenade sediment och farliga ämnen från förorenade sediment. Den totala budgeten är cirka SEK 30 miljoner som ska fördelas över tre år.
Closing date: 7 September 2020
Support for Nordic research projects in medicine - Olav Thon Foundation
Support Nordic research projects in reparative medicine targeting diseases in the musculoskeletal and peripheral and central nervous system. Grants are worth up to NOK 2.5 million per year for up to four years.
Closing date: 15 September 2020
International research award for mathematics, natural sciences and medicine - Olav Thon Foundation
Recognises excellent research in the field of mathematics, natural sciences and medicine. The award is worth NOK 5 million.
Closing date: 15 September 2020
Great grant for thrombosis researchers - European Society of Cardiology
The European Society of Cardiology’s Working Group on Thrombosis invites applications for its great grant for thrombosis researchers. This enables young scientists to gain training in basic research techniques in the field of atherothrombosis at well-known high quality research laboratories.
Applicants must be under 35 years of age and must have a written invitation from a basic research laboratory in a specific basic research technique. Applicants must not be supported by any other grant or sponsorship. Grants are worth up to €2,000 per month for a maximum of €12,000.
Closing date: 15 June 2020
EXTENDED DEADLINE: Future leaders mentorship programme for clinical diabetologists - European Association for the Study of Diabetes
The European Foundation for the Study of Diabetes, with support from AstraZeneca, invites applications for its future leaders mentorship programme for clinical diabetologists. This aims to identify and promote the advancement of the next generation of leading clinical diabetologists in Europe. Mentees will pursue a research project under the guidance of their mentor, and participate in a tailor-made continuing education programme.
Clinical academic diabetologists, who are clinically qualified in medicine and who have between three and 10 years of experience in their field at a relatively senior level but normally without a tenured academic faculty position, may apply. Applicants must be members of the EASD. Awards are worth USD 25,000 each per year over up to three years.
Closing date: 30 June 2020
The European Crohn’s and Colitis Organisation invites applications for its grants. These support innovative scientific research in the area of inflammatory bowel diseases in Europe.
Young basic or clinical scientists up to the age of 40, or above if within five years of finishing gastrointestinal training or PhD graduation. They must be members of the society. Research is usually undertaken at the applicant’s home institution.
Awards are worth €80,000, for a period of one year.
Closing date: 31 July 2020
EXTENDED DEADLINE: N-ECCO research grant - European Crohn's and Colitis Organisation
The European Crohn’s and Colitis Organisation invites applications for the N-ECCO research grant. This enables inflammatory bowel disease nurses to participate in international research projects across Europe. The aim is to engage nurses who are less experienced in research to conduct more research and be mentored by senior researchers. The PI must be an ECCO member. The award is worth €20,000 for a period of one year.
Closing date: 31 July 2020
Federal Funding agencies
BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional): NIH
This Funding Opportunity Announcement (FOA) solicits grant applications in two related but distinct areas. The first area is in the development and testing of novel tools and methods of neuromodulation that go beyond the existing forms of neural stimulation. The second distinct area that this FOA seeks to encourage is the optimization of existing stimulation methods.
Closing date: October 15, 2020 by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-MH-20-310
BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21 Clinical Trial Not Allowed): NIH
A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While currently available technologies can provide some understanding, they may not be sufficient to accomplish this goal. This FOA seeks applications for unique and innovative technologies that are in an early stage of development, including new and untested ideas that are in the initial stages of conceptualization.
In addition to experimental approaches, the support provided under this FOA might enable calculations, simulations, computational models, or other mathematical techniques for demonstrating that the signal sources and/or measurement technologies are theoretically capable of meeting the demands of large-scale recording or manipulation of circuit activity in humans or in animal models. The support might also be used for building and testing phantoms, prototypes, in-vitro or other bench-top models in order to validate underlying theoretical assumptions in preparation for future FOAs aimed at testing in animal models.
Closing date: October 29, 2020, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-EY-18-001
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed): NIH
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the participating ICs.
Closing date: November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-18-830
Established investigator grant, Scleroderma Foundation, US
The Scleroderma Foundation seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.
Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences; must have completed a postdoctoral fellowship; and have been principal investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past.
Applicants may request up to $75,000 (Up to 8 percent of the direct costs per year of award may be set aside as indirect costs. The indirect cost amount will be subtracted from the yearly total [up to $75,000] of the award) per year for up to two years (total for two years not to exceed $150,000).
Closing date: 5th of September 2020, 5 p.m. Eastern time